Hung Kam Cheung - Concepedia

Author

Hung Kam Cheung

Also Known As

H CHEUNG, H-Kam Cheung, H. -Kam Cheung, H. Kam Cheung, H.-K. Cheung, H.-Kam Cheung, H.K. Cheung, H.Kam Cheung, Ho Wa Oliver Cheung, Hung Kam Cheung

Publications

881

Citations

H-Index

Concepts

All Affiliations

Biogen (United States)University of Pennsylvania Amgen (United States)

About

Hung Kam Cheung is an author at Biogen (United States) specializing in medicine, cancer therapeutics, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	373
2	Engineering	1	1	166
3	Health Sciences	1	1	207
4	Biomedical Engineering	1	1	166
5	Hepatology	1	1	207

Hung Kam Cheung

Publications

850

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial Thomas U. Marron, Maria Isabel Fiel, Pauline Hamon, The Lancet. Gastroenterology & hepatology Surgical OncologyHepatologyResectable Hepatocellular CarcinomaNeoadjuvant CemiplimabMedicine	2022	207
Successful shape-Based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI) Juswinder Singh, Claudio Chuaqui, P. Ann Boriack‐Sjodin, Bioorganic & Medicinal Chemistry Letters Virtual ScreeningTgfβ Receptor KinaseEngineeringPotent InhibitorReceptor Tyrosine Kinase	2003	166
A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth <i>In vivo</i> and Prevents Tumor Recurrence after Surgical Resection Eiji Suzuki, Samuel Kim, Hung Kam Cheung, Cancer Research	2007	113
SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model Kai Fu, Michael J. Corbley, Lihong Sun, Arteriosclerosis Thrombosis and Vascular Biology	2008	84
Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy Samuel Kim, George Buchlis, Zvi G. Fridlender, Cancer Research	2008	83
Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity Eiji Suzuki, Veena Kapoor, Hung Kam Cheung, Clinical Cancer Research	2004	64
An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer. Matthew P. Rausch, Tobias Hahn, Lalitha Ramanathapuram, PubMed	2009	42
Biodistribution and PET Imaging of Labeled Bispecific T Cell–Engaging Antibody Targeting EpCAM Frank J. Warnders, Stijn J.H. Waaijer, Martin Pool, Journal of Nuclear Medicine	2016	37
Molecular Imaging of Radiolabeled Bispecific T-Cell Engager 89Zr-AMG211 Targeting CEA-Positive Tumors Stijn J.H. Waaijer, Frank J. Warnders, Sabine Stienen, Clinical Cancer Research	2018	28
Effects of nocodazole, a new synthetic microtubule inhibitor, on movement and spreading of mouse peritoneal macrophages Hung Kam Cheung, Doris E. Terry Cell Biology International Reports	1980	26

Page 1